AXIM BIOTECHNOLOGIES, INC. (AXIM)

0.00 +33.33% (+0.00)

Over 6M: -61.9%

2026-08-28
0.01 0.01
Mar Apr May Jun Jul Aug

Financials Quarterly

Q3 '19 — Revenue: 0 Q3 '19 — Operating Cash Flow: -1.8M Q3 '19 — Net Income: -863.6K Q4 '19 — Revenue: 799.5K Q4 '19 — Operating Cash Flow: -1.4M Q4 '19 — Net Income: -1.4M Q1 '20 — Revenue: 0 Q1 '20 — Operating Cash Flow: -1.1M Q1 '20 — Net Income: -2M Q2 '20 — Revenue: 0 Q2 '20 — Operating Cash Flow: -737.1K Q2 '20 — Net Income: -79.4K Q3 '20 — Revenue: 0 Q3 '20 — Operating Cash Flow: -790.2K Q3 '20 — Net Income: -1.9M Q4 '20 — Revenue: 0 Q4 '20 — Operating Cash Flow: -614.9K Q4 '20 — Net Income: -2.4M Q1 '21 — Revenue: 32.6K Q1 '21 — Operating Cash Flow: -565.5K Q1 '21 — Net Income: -864.5K Q2 '21 — Revenue: 14.9K Q2 '21 — Operating Cash Flow: -595.5K Q2 '21 — Net Income: -3.8M Q3 '21 — Revenue: 8.1K Q3 '21 — Operating Cash Flow: -532.8K Q3 '21 — Net Income: -3.3M Q4 '21 — Revenue: 4.8K Q4 '21 — Operating Cash Flow: -792.9K Q4 '21 — Free Cash Flow: -813.4K Q4 '21 — Net Income: -8M Q1 '22 — Revenue: 0 Q1 '22 — Operating Cash Flow: -703.7K Q1 '22 — Net Income: -2.1M Q2 '22 — Revenue: 0 Q2 '22 — Operating Cash Flow: -703.9K Q2 '22 — Net Income: -1.2M Q3 '22 — Revenue: 1.3K Q3 '22 — Operating Cash Flow: -321.2K Q3 '22 — Free Cash Flow: -323.9K Q3 '22 — Net Income: -2M Q4 '22 — Revenue: 7.6K Q4 '22 — Operating Cash Flow: -315.5K Q4 '22 — Free Cash Flow: -315.5K Q4 '22 — Net Income: -899K Q1 '23 — Revenue: 7.4K Q1 '23 — Operating Cash Flow: -142K Q1 '23 — Net Income: -2.8M Q2 '23 — Revenue: 9.9K Q2 '23 — Operating Cash Flow: -643.6K Q2 '23 — Net Income: -3.7M Q3 '23 — Revenue: 9.6K Q3 '23 — Operating Cash Flow: -264.5K Q3 '23 — Net Income: 328.5K Q4 '23 — Revenue: 12.9K Q4 '23 — Operating Cash Flow: 19.6K Q4 '23 — Free Cash Flow: 19.6K Q4 '23 — Net Income: -1.9M Q1 '24 — Revenue: 53K Q1 '24 — Operating Cash Flow: -252.5K Q1 '24 — Free Cash Flow: -255.3K Q1 '24 — Net Income: -292.3K Q2 '24 — Revenue: 17.5K Q2 '24 — Operating Cash Flow: -261.5K Q2 '24 — Net Income: -2.3M -8M -6M -4M -2M 0 2M
Q4 '19 Q3 '20 Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q2 '24
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2024-06-30, reported in USD. The newest fact in the filings is dated 2024-06-30, 791 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

0.6
SBC / sales 98.7%
OE margin -915.8%
Oper. margin -2490.3%
Accruals -90.6%
Gross margin 98.1%
Asset turnover 0.025×
EBITDA margin -2027.9%
FCF margin -817.0%
OCF margin -817.0%
ROA -110.9%
Capex / sales —
OCF / EBIT —
Profit margin —
ROCE —
ROE —
ROIC —

4 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

4.5
RPO / sales 2.5×
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

1.2
ND/EBITDA —
Current ratio 0.0032×
Interest cover -11.0×
Cash / Debt 0.001×
F-score 3.0 pts
Quick ratio 2.3e-05×
Cash runway —
Debt / Eq —
Debt payback —
Equity / Assets —
Net debt / Eq —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

6.5
Sales/sh Y/Y +254.6%
Sales CAGR 4Y -52.8%
Sales Q/Q +76.0%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —
Shares change —

3 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.